XORTX Therapeutics Inc (XRTX)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
XORTX Therapeutics Shareholders Equity (Quarterly): 2.705M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.705M |
| March 31, 2024 | 2.491M |
| December 31, 2023 | 4.642M |
| September 30, 2023 | 6.086M |
| June 30, 2023 | 7.398M |
| March 31, 2023 | 9.059M |
| December 31, 2022 | 6.997M |
| September 30, 2022 | 7.829M |
| June 30, 2022 | 9.502M |
| March 31, 2022 | 10.73M |
| December 31, 2021 | 13.20M |
| September 30, 2021 | -3.323M |
| June 30, 2021 | 2.678M |
| March 31, 2021 | 2.750M |
| December 31, 2020 | 0.9852M |
| September 30, 2020 | 1.248M |
| June 30, 2020 | 1.468M |
| March 31, 2020 | 1.543M |
| December 31, 2019 | -0.1621M |
| September 30, 2019 | -0.0762M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0157M |
| March 31, 2019 | 0.1216M |
| December 31, 2018 | 0.2361M |
| September 30, 2018 | 0.3563M |
| June 30, 2018 | 0.5689M |
| March 31, 2018 | 0.7729M |
| December 31, 2017 | -0.5206M |
| November 30, 2017 | 0.0328M |
| September 30, 2017 | -0.3467M |
| August 31, 2017 | 0.0491M |
| May 31, 2017 | 0.0963M |
| February 28, 2017 | 0.1344M |
| November 30, 2016 | 0.3331M |
| August 31, 2016 | 0.1307M |
| May 31, 2016 | 0.1711M |
| February 29, 2016 | 0.1973M |
| November 30, 2015 | 0.2302M |
| August 31, 2015 | 0.0446M |
| May 31, 2015 | 0.085M |
| February 28, 2015 | 0.0959M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.323M
Minimum
Sep 2021
13.20M
Maximum
Dec 2021
4.623M
Average
2.750M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 388.00M |
| Edesa Biotech Inc | 2.867M |
| Lexaria Bioscience Corp | 10.12M |
| Xenon Pharmaceuticals Inc | 844.05M |
| ESSA Pharma Inc | 128.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.799M |
| Total Liabilities (Quarterly) | 2.095M |